What is it about?
Epidemiology of benign prostatic hyperplasia (BPH) is incompletely understood. The following study was done to estimate the prevalence of BPH according to obstructive and irritative symptoms of prostate obstruction determined by uroflowmetry and prostate size. In a cross-sectional study a total of 8,466 men aged 40 or older were interviewed by 74 general practitioners and answered the International Prostate Symptom Score (I-PSS) questionnaire.
Photo by Free To Use Sounds on Unsplash
Why is it important?
Traditionally, epidemiology is the description of epidemics, which are occurrences of diseases that significantly affect various groups of people. Nearly all men will develop histological benign prostatic hyperplasia (BPH) by the age of 80. The disease is now known to adversely affect the quality of life of around one man in three over the age of 50. The prevalence of histologic BPH can be determined only from autopsy studies.
Read the Original
This page is a summary of: Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older, International Urology and Nephrology, February 2008, Springer Science + Business Media, DOI: 10.1007/s11255-008-9338-7.
You can read the full text:
The following have contributed to this page